2018
DOI: 10.1038/s41431-018-0124-4
|View full text |Cite
|
Sign up to set email alerts
|

Whole-exome sequence analysis highlights the role of unmasked recessive mutations in copy number variants with incomplete penetrance

Abstract: Several hypotheses have been proposed to explain the phenotypic variability between parent and offspring carrying the same genomic imbalance, including unmasking of a recessive variant by a chromosomal deletion. Here, 19 patients with neurodevelopmental disorders harboring a rare deletion inherited from a healthy parent were investigated by whole-exome sequencing to search for SNV on the contralateral segment. This strategy allowed us to identify a candidate variant in two patients in the NUP214 and NCOR1 gene… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
6
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 23 publications
1
6
0
Order By: Relevance
“…43 Recent work on recessive variants unmasked by chromosomal deletions has pointed to a single base-pair deletion in human NUP214 as a candidate disease-causing pathogenic variant in the case of a neurodevelopmental disorder. 44 Another recent report 45 describes a similar clinical phenotype to the one in our study, consisting of severe encephalopathy and microcephaly and associated with a different biallelic variant in NUP214. An intriguing new study by Bonin et al identifies biallelic variants in human NUP88 as a novel cause of lethal fetal akinesia deformation sequence (FADS [MIM: 208150]) in two families.…”
Section: Discussionsupporting
confidence: 80%
“…43 Recent work on recessive variants unmasked by chromosomal deletions has pointed to a single base-pair deletion in human NUP214 as a candidate disease-causing pathogenic variant in the case of a neurodevelopmental disorder. 44 Another recent report 45 describes a similar clinical phenotype to the one in our study, consisting of severe encephalopathy and microcephaly and associated with a different biallelic variant in NUP214. An intriguing new study by Bonin et al identifies biallelic variants in human NUP88 as a novel cause of lethal fetal akinesia deformation sequence (FADS [MIM: 208150]) in two families.…”
Section: Discussionsupporting
confidence: 80%
“…Whilst researchers are starting to sequence cohorts of individuals with large “Mb-sized” deletions [ 21 , 89 , 90 ] and performing SNV and CNV analysis in one combined WGS assay, it is imperative for clinical and diagnostic genomicists to foster guidelines that facilitate routine genomic sequencing (ES or WGS) on patients who are found to have recurrent genomic deletions, i.e., NAHRdelCNV, that will benefit both the patients and the research human subjects worldwide. Given the great potential in the near future for disease gene discoveries within intervals of genomic disorder deletion CNVs, these patients will benefit from routine or perhaps even more prioritized reanalysis of sequencing data [ 91 ].…”
Section: Discussionmentioning
confidence: 99%
“…Even when available subject numbers are limited for recurrent genomic deletions with extremely low penetrance, it is possible to tune the disease gene/allele characterization strategy by targeting specific phenotypes, as demonstrated at the Smith Magenis Syndrome -MYO15 locus two decades ago (Liburd et al 2001). While researchers are starting to sequence cohorts of individuals with large deletions (Egloff et al 2018;Beck et al 2019;Zhao et al 2020), it is imperative for clinical and diagnostic genomicists to foster guidelines that facilitate routine genomic sequencing (ES or WGS) on patients who are found to have recurrent genomic deletions, which will benefit both the patients and the research enterprises worldwide. Given the great potential in the near future for disease gene discoveries within intervals of genomic deletions, these patients will benefit from routine or perhaps even more prioritized reanalysis of sequencing data (Liu et al 2019b).…”
Section: Discussionmentioning
confidence: 99%
“…Whilst researchers are starting to sequence cohorts of individuals with large ‘Mb-sized’ deletions (Egloff et al 2018; Beck et al 2019; Zhao et al 2020) and performing SNV and CNV analysis in one combined WGS assay, it is imperative for clinical and diagnostic genomicists to foster guidelines that facilitate routine genomic sequencing (ES or WGS) on patients who are found to have recurrent genomic deletions, i.e. NAHRdelCNV, that will benefit both the patients and the research human subjects worldwide.…”
Section: Discussionmentioning
confidence: 99%